Additional file 2 of Understanding the causes and consequences of low statin adherence: evidence from UK Biobank primary care data

Additional file 2: Table 1-ICD10 codes for the cardiovascular diseases. Table 2-Details of the polygenic scores ascertained from UK Biobank release and systematic evaluation of optimized polygenic risk scores for 53 diseases and quantitative traits. Table 3-Read codes for low-density lipoprotein in UK Biobank primary care data. Table 4-Polygenic Scores and LDL change associations (LDL1/LDL0) in statin patients. Table 5-The weighted Pearson correlations between the exposure and confounding covariates with the CBPS weights. Table 6-The weighted Spearman correlations between the exposure and confounding covariates with the CBPS weights. Table 7-The weighted OLS regression results with the CBPS weights. Table 8-The weighted OLS regression results with the npCBPS weights. Table 9-Sensitivity analysis: the weighted OLS regression results with the CBPS weights in the primary prevention subgroup. Table 10-Sensitivity analysis: the weighted OLS regression results with the npCBPS weights in the primary prevention subgroup. Table 11-Polygenic scores of traits and diseases associations with PDC in statin patients. Table 12-GWAS results for two PDC phenotype. Table 13-GWAS Results for PDC Binary Phenotype (< = 95% vs > 95%) and Previously Reported Nominal Associations with Muscle Symptoms. Table 14-Time to event analysis in statin patients for incident clinical outcomes.